Impact News +++ Ambarella surges after report says company exploring strategic options, including sale (SeekingAlpha) +++ AMBARELLA Aktie +15,53%

Gewinn & Umsatz News zur SAREPTA Aktie

>SAREPTA Aktienkurs

16.465 EUR +1.1% (Tradegate)

Ask: 16.445 EUR / 1000 Stück

Bid: 16.375 EUR / 1000 Stück

Tagesumsatz: 2830 Stück

Realtime Kurs von 8 bis 22 Uhr!

SAREPTA Aktie über LYNX handeln

Intraday

1 Jahr

>SAREPTA Performance

1 Woche: -9,7%

1 Monat: -50,8%

3 Monate: -76,2%

6 Monate: -85,7%

1 Jahr: -89,1%

laufendes Jahr: -85,8%

>SAREPTA Aktie

Name:

SAREPTA THERAP. DL-,0001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US8036071004 / A1J1BH

Symbol/ Ticker:

AB3A (Frankfurt) / SRPT (NASDAQ)

Kürzel:

FRA:AB3A, ETR:AB3A, AB3A:GR, NASDAQ:SRPT

Index:

Webseite:

https://www.sarepta.com/

Marktkapitalisierung:

3070 Mio. EUR

Umsatz:

1930.72 Mio. EUR

EBITDA:

-67.75 Mio. EUR

Gewinn je Aktie:

-1.974 EUR

Schulden:

1177.48 Mio. EUR

Liquide Mittel:

452.6 Mio. EUR

Umsatz-/ Gewinnwachstum:

80.2% / -

KGV/ KGV lG:

166.54 / 23.87

KUV/ KBV/ PEG:

1.78 / 3.14 / -

Gewinnm./ Eigenkapitalr.:

-11.12% / -23.61%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

SAREPTA, AVI BIOPHARMA

Letzte Datenerhebung:

24.06.25

>SAREPTA Eigentümer

Aktien: 98.28 Mio. St.

f.h. Aktien: 93.86 Mio. St.

Insider Eigner: 4.44%

Instit. Eigner: 90.39%

Leerverk. Aktien: 9.7%

>SAREPTA Peer Group

BAVARIAN NORDIC ADR

CARDINAL HEALTH

CYTOKINETICS

DANAHER

DAVITA

LONZA ADR

MCKESSON

TAKEDA ADR

VALNEVA ADR

VIATRIS

>SAREPTA Chart & Kurs - NASDAQ

>SAREPTA Gewinn & Umsatz News

09.05.25 - 15:42	Sarepta′s Week Goes From Bad to Worse on FDA Fears, Outlook Cut (Bloomberg)
	Sarepta Therapeutics Inc. is on pace for its worst week in four years as disappointing earnings and regulatory fears hit the drugmaker's shares....

26.02.25 - 22:42	Sarepta Therapeutics Q4 Profit Increases, But Misses Estimates (AFX)
	WASHINGTON (dpa-AFX) - Sarepta Therapeutics (SRPT) announced a profit for its fourth quarter that increased from the same period last year but missed the Street estimates.The company's bottom line......

06.11.24 - 23:02	Sarepta Therapeutics Q3 Earnings Summary (AFX)
	WASHINGTON (dpa-AFX) - Below are the earnings highlights for Sarepta Therapeutics (SRPT):Earnings: $33.6 million in Q3 vs. -$40.9 million in the same period last year. EPS: $0.34 in Q3 vs. -$0.46 ......

07.08.24 - 23:51	Sarepta Therapeutics Inc reports results for the quarter ended in June - Earnings Summary (Reuters EN)
	Sarepta Therapeutics Inc reports results for the quarter ended in June - Earnings Summary...

07.08.24 - 23:12	Sarepta Therapeutics Q2 Earnings Summary (AFX)
	WASHINGTON (dpa-AFX) - Below are the earnings highlights for Sarepta Therapeutics (SRPT):Earnings: $6.46 million in Q2 vs. -$23.94 million in the same period last year. EPS: $0.07 in Q2 vs. -$0.27......

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Was man zu lang bedenkt, das wird bedenklich. - Sprichwort

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram